PTC Therapeutics, Inc. PTCT
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Joel Beatty | Robert W. Baird | 45.38 $ | 70 $ | 24.62 % | 08/08/2025 |
| Joel Beatty | Robert W. Baird | 36.19 $ | 66 $ | 29.81 % | 07/05/2025 |
| Brian Abrahams | RBC Capital | 44.61 $ | 58 $ | 13.39 % | 07/01/2025 |
| Joel Beatty | Robert W. Baird | 45.085 $ | 52 $ | 6.92 % | 27/11/2024 |
| Jeffrey Hung | Morgan Stanley | 38.48 $ | 45 $ | 6.52 % | 11/10/2024 |
| Colin Bristow | UBS | 34.99 $ | 47 $ | 12.01 % | 26/08/2024 |
| Jeffrey Hung | Morgan Stanley | 33.2 $ | 32 $ | -1.20 % | 12/07/2024 |
| Paul Choi | Goldman Sachs | 40.12 $ | 32 $ | -8.12 % | 20/05/2024 |
| Kelly Shi | Jefferies | 39.81 $ | 46 $ | 6.19 % | 20/05/2024 |
| Jeffrey Hung | Morgan Stanley | 28.57 $ | 30 $ | 1.43 % | 26/04/2024 |
| Brian Abrahams | RBC Capital | 38.29 $ | 46 $ | 7.71 % | 23/06/2022 |
| Kristen Kluska | Cantor Fitzgerald | 43.64 $ | 63 $ | 19.36 % | 05/04/2022 |
| Colin Bristow | UBS | 43.65 $ | 45 $ | 1.35 % | 31/08/2021 |